Evidence map›Paper›PMID 39678411›Full record

ArticleGland surgery2024

Comparison of clinical characteristics and pathologic complete response rate after neoadjuvant chemotherapy in women under 35 years and older women with breast cancer.

He Dou, Tian Gao, Zhaoting Li, Siyuan Jia, Danli Luo, Yuling Ba, Fucheng Li, Jianan Wang, Min Xiao

Abstract read
In one paragraph

Article in Gland surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

He Dou *Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Tian Gao *Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Zhaoting Li *Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Siyuan JiaDepartment of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Danli LuoDepartment of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Yuling BaDepartment of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Fucheng LiDepartment of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Jianan WangDepartment of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Min XiaoDepartment of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Age has been confirmed as a very aggressive biological factor associated with the poor prognosis of breast cancer (BC) patients. However, the understanding of young women with breast cancer (YWBC) is scarce. This study compares and evaluates the clinical characteristics and pathologic complete response (pCR) rate after neoadjuvant chemotherapy (NAC) in YWBC and older women with BC. Methods: We retrospectively analyzed the clinicopathological data and pCR rates of 1,419 non-metastatic BC patients from the Harbin Medical University Cancer Hospital from 1 January 2012 to 31 December 2019. Patients were classified according to age (≤35 Results: A total of 879 patients in this study were eligible for analysis, and 71 (8.1%) female patients were ≤35 years old. Compared with elderly patients, YWBC were more likely to achieve pCR (25.4% Conclusions: Our study found that age is the main factor affecting the achievement of pCR in patients with BC. Chemotherapy is more effective in patients with YWBC. We need to pay more attention to this group and achieve individualized treatment, which will facilitate improved treatment of BC and provide new targets and blueprints for clinical therapy.

Indexed as

body mass index (BMI)Breast cancer (BC)neoadjuvant chemotherapy (NAC)pathologic complete response (pCR)young women with breast cancer (YWBC)

Identifiers

PMID39678411
PMCPMC11635561

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.